查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
2049427

大腸桿菌檢測市場規模、佔有率、趨勢和預測：按產品類型、檢測類型、最終用戶和地區分類，2026-2034 年

E. Coli Testing Market Size, Share, Trends and Forecast by Product, Test Type, End User, and Region, 2026-2034
出版日期: | 出版商: IMARC | 英文 142 Pages | 商品交期: 2-3個工作天內

價格

2025年全球大腸桿菌檢測市場規模為24億美元。展望未來，IMARC Group預測，該市場將以6.12%的複合年成長率從2026年成長至2034年，到2034年達到42億美元。目前，北美市場佔據主導地位，預計2025年將佔據超過35.8%的市場。該地區市場成長的主要促進因素是嚴格的監管規程、完善的醫療保健基礎設施以及對水和食品安全檢測日益成長的需求。

全球大腸桿菌檢測市場持續擴張，主要驅動力在於人們對水源性和食源性疾病的認知不斷提高，以及水和食品安全法規結構的日益完善。大腸桿菌疫情的增加加速了新興市場和已開發國家對創新檢測方法的需求。此外，分子診斷技術的創新和自動化檢測系統的日益普及也進一步推動了市場成長。同時，公眾健康意識的增強，尤其是在都市區，促使人們對先進的檢測基礎設施進行大量投資，從而推動了全球大腸桿菌檢測解決方案的擴展。

美國在全球大腸桿菌檢測市場佔有重要佔有率，這主要歸功於其嚴格的食品安全政策、完善的醫療保健基礎設施以及公眾對食源性疾病日益增強的認知。食品飲料產業大腸桿菌疫情的頻繁顯著提升了對可靠檢測解決方案的需求。例如，2024年11月，美國領先的胡蘿蔔生產商Grimway Farms在發生大腸桿菌疫情後召回了其有機小胡蘿蔔，導致美國18個州共確診39例病例。此外，對研發項目的投入增加以及快速檢測技術的進步也推動了市場成長。同時，包括美國農業部（USDA）和食品藥物管理局（FDA）在內的監管機構的嚴格監管，促使許多公司迅速採用尖端診斷工具來應對風險並確保消費者安全。這種健全的監管環境為市場的持續成長提供了支撐。

大腸桿菌檢測市場趨勢：

對快速診斷測試的需求日益成長

對主要由大腸桿菌（E. coli）引起的胃腸道感染疾病進行快速診斷的需求日益成長，推動了快速診斷調查方法的發展。傳統的實驗室培養方法需要兩週時間才能鑑定出大腸桿菌，而像賽默飛世爾科技的TaqPath腸道細菌選擇性檢測板這樣的新型基於PCR的檢測方法，可以在大約兩小時內提供結果。這種快速出結果的方式使醫護人員能夠更快地診斷和治療感染疾病，從而縮短患者的等待時間和住院時間。例如，一項研究報告稱，TaqPath檢測板的敏感度和特異性均超過98%，能夠持續提供可靠的結果。快速診斷方法的普及在控制食物中毒爆發集體爆發發揮了至關重要的作用，使及時干預能夠減輕感染的傳播和影響。此外，單次檢測即可處理93個檢體，提升了檢查室的處理能力，即使在高通量臨床環境中也能實現快速診斷。

人們越來越關注食品安全法規

全球日益嚴格的食品安全法規推動了對先進大腸桿菌檢測解決方案的需求。監管機構強調必須遵守檢測規程，以降低食品生產和分銷鏈中的污染風險。例如，產業報告顯示，在美國，每年約有73,000人因大腸桿菌污染而患病，導致約2,200人住院治療，61人死亡。此外，這一趨勢正在推動自動化檢測系統的應用，這些系統能夠提供可靠且可重複的結果，在確保合規性的同時最佳化營運效率。同時，消費者對食品安全和衛生意識的提高也進一步促使產業投資強大的檢測系統，以保護公眾健康並維護品牌信譽。

擴大即時檢測範圍

即時檢測（POC​​）大腸桿菌正日益受到分子診斷技術的支持，例如PCR、LAMP和質譜分析。這些技術能夠快速、現場檢測水、食品和糞便樣本中的病原體。特別是PCR技術，對於檢測水和糞便樣本中的大腸桿菌至關重要，它為醫護人員提供了一種更可靠的方法，以便即時診斷感染疾病並啟動治療。 LAMP DNA擴增技術也能一步檢測食品、糞便和環境樣本中的大腸桿菌，其操作流程適用於現場應用和資源有限的環境。根據一篇研究論文顯示，質譜分析也被用於細菌和病毒（例如大腸桿菌）的分型，因此可以詳細研究感染亞型和來源。免疫磁分離（IMS）技術能夠提高從環境水樣本中回收大腸桿菌O157:H7的效率，這對於疫情調查至關重要。其他新興技術，包括 CRISPR/Cas 平台和基於智慧型手機的數位方法，正在提高大腸桿菌檢測的便利性和速度，並進一步推動分子診斷在即時檢測 (POC) 環境中的應用。這些創新有助於提高診斷效率和速度，尤其是在急診醫學和偏遠地區，從而降低醫療成本並改善患者預後。

目錄

第1章：序言

第2章：調查方法

  • 調查目的
  • 相關利益者
  • 數據來源
    • 主要訊息
    • 二手資訊
  • 市場估值
    • 自下而上的方法
    • 自上而下的方法
  • 預測方法

第3章執行摘要

第4章：引言

第5章：全球大腸桿菌檢測市場

  • 市場概覽
  • 市場表現
  • 新冠疫情的影響
  • 市場預測

第6章 市場區隔：依產品分類

  • 消耗品
  • 裝置

第7章 市場區隔：依測試類型分類

  • 環境測試
    • 主要類型
      • 膜過濾（MF）
      • 多管發酵（MTF）
      • 酵素基材法
  • 臨床試驗
    • 主要類型
      • 聚合酵素鏈鎖反應（PCR）檢測
      • 酵素免疫分析法（EIA）
      • 其他

第8章 市場區隔：依最終用戶分類

  • 醫院和診所
  • 診斷檢查室
  • 其他

第9章 市場區隔：依地區分類

  • 北美洲
    • 美國
    • 加拿大
  • 亞太地區
    • 中國
    • 日本
    • 印度
    • 韓國
    • 澳洲
    • 印尼
    • 其他
  • 歐洲
    • 德國
    • 法國
    • 英國
    • 義大利
    • 西班牙
    • 俄羅斯
    • 其他
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 其他
  • 中東和非洲

第10章 SWOT 分析

第11章：價值鏈分析

第12章：波特五力分析

第13章：價格分析

第14章 競爭格局

  • 市場結構
  • 大公司
  • 主要公司簡介
    • Accugen Laboratories Inc.
    • Alere Inc.（Abbott Laboratories）
    • BD（Becton Dickinson and Company）
    • bioMerieux（INSTITUT MERIEUX）
    • Bio-RAD Laboratories Inc.
    • Enzo Life Sciences Inc.（Enzo Biochem Inc.）
    • Idexx Laboratories Inc.
    • Johnson & Johnson
    • Meridian Bioscience Inc.
    • Nanologix Inc.
    • Pro-Lab Diagnostics
    • Qiagen NV
    • Thermo Fisher Scientific Inc.
Product Code: SR112026A2368

The global E. coli testing market size was valued at USD 2.4 Billion in 2025. Looking forward, IMARC Group estimates the market to reach USD 4.2 Billion by 2034, exhibiting a CAGR of 6.12% from 2026-2034. North America currently dominates the market, holding a market share of over 35.8% in 2025. This regional market is mainly influenced by strict regulatory protocols, robust healthcare infrastructure, and magnified requirement for water and food safety testing.

The global E. coli testing market is witnessing expansion chiefly due to heightening awareness regarding water and foodborne illnesses, combined with stricter regulatory frameworks for water and food safety. Amplifying incidents of E. coli outbreaks have incentivized accelerated need for innovative testing methods in emerging as well as developed regions. In addition to this, technological innovations in molecular diagnostics and the bolstering utilization of automated testing systems are further fueling market growth. Moreover, the growing emphasis on public sanitation and health, specifically in urban zones, is prompting heavy investments in advanced testing infrastructure, magnifying the adoption of E. coli testing solutions worldwide.

The United States accounts for a crucial share in the global E. coli testing market, majorly propelled by stringent implementation of food safety policies, resilient healthcare infrastructure, and amplifying public awareness associated with foodborne illnesses. The heightening occurrence of E. coli outbreaks in the food and beverage sector has significantly strengthened the requirement for dependable testing solutions. For instance, in November 2024, Grimmway Farms, a prominent U.S.-based carrot producer, recalled organic baby carrots due to E. coli outbreak, resulting in 39 cases across 18 U.S. states. In addition, elevating investments in research projects and advancements in rapid testing technologies further aid in market expansion. Furthermore, with regulatory bodies, encompassing the USDA and FDA enforcing stringent adherence, several businesses are rapidly opting for leading-edge diagnostic tools to address risks and facilitate customer safety. This resilient regulatory landscape supports constant market growth.

E. OLI TESTING MARKET TRENDS:

GROWING DEMAND FOR RAPID DIAGNOSTIC TESTS

Increases in the demand for quicker diagnostics in gastrointestinal infections, with the pathogen E. coli among the most relevant, have led towards high-speed testing methodologies. While classical laboratory culture takes two weeks for identification of the organism E. coli, newer PCR-based tests, such as Thermo Fisher's TaqPath Enteric Bacterial Select Panel, yield results within approximately two hours. This rapid turnaround allows health providers to diagnose and treat infections more promptly, which consequently decreases patient wait times and hospital stays. For instance, according to a research article, the TaqPath panel provides sensitivity and specificity of over 98%, ensuring that the results are always dependable. The trending towards fast diagnostic methods has been crucial in controlling foodborne disease outbreaks by being able to intervene in a timely manner to reduce the spread and effect of infections. It also allows for testing 93 samples in one run, which can improve laboratory throughput and increase the possibility of rapid diagnosis even with high-volume clinical settings.

INCREASING FOCUS ON FOOD SAFETY REGULATIONS

Stringent food safety regulations globally are propelling the demand for advanced E. coli testing solutions. Regulatory bodies are emphasizing compliance with testing protocols to mitigate risks of contamination in food production and distribution chains. For instance, as per industry reports, E. coli contamination causes approximately 73,000 illnesses each year in the U.S., resulting in around 2,200 hospitalizations and 61 fatalities. Moreover, this trend is driving the adoption of automated testing systems that deliver reliable and reproducible results, ensuring compliance while optimizing operational efficiency. In addition, rising consumer awareness regarding food safety and hygiene is further encouraging industries to invest in robust testing frameworks to safeguard public health and maintain brand integrity.

EXPANSION OF POINT-OF-CARE TESTING

Point-of-care (POC) testing for E. coli increasingly gains support through molecular diagnostic technologies like PCR, LAMP, and mass spectrometry, which provide rapid, on-site results for pathogens in water, food, and stool samples. PCR, particularly, is requisite for the detection of E. coli from water and stool samples, providing a more reliable method for healthcare providers to diagnose infections and initiate treatment in real time. The LAMP DNA amplification technique can also sense the presence of E. coli in food, stool and environmental samples in one step using a process that could be suited for field applications as well as resource-limited settings. According to a research article, the use of mass spectrometry is also realized in the typing of bacteria and viruses, such as E. coli, to study the subtypes and sources of infection in detail. IMS (immunomagnetic separation) facilitates the increase in the yield of recovery of E. coli O157:H7 from environmental water samples essential for outbreak studies. Other emerging technologies, including CRISPR/Cas platforms and smartphone-based digital methods, improve the accessibility and speed of E. coli detection, further pushing the adoption of molecular diagnostics in POC settings. These innovations contribute to more efficient and timely diagnosis, reducing healthcare costs and improving patient outcomes, particularly in urgent care and remote areas.

E. COLI TESTING INDUSTRY SEGMENTATION:

ANALYSIS BY PRODUCT:

  • Consumables
  • Instruments

Consumables leads the market with around 83.7% of market share in 2025. This domination is principally propelled by the elevated frequency of test utilization and the requirement for disposable items to guarantee contamination-free and precise results. This category encompasses media, reagents, and test kits leveraged across variety of testing platforms. The recurring profile of consumables in diagnostics prompts a stable need, specifically in major industries, typically including water quality and food safety testing. Furthermore, with the magnifying cases of E. coli outbreaks, the market is actively witnessing amplified utilization of ready-to-use testing kits that adhere to laboratory workflows. Advancements in consumable design, like automated and pre-packaged systems, further improve both precision and efficacy, positioning them as requisite component for on-site as well as laboratory testing. This segment's expansion is highlighted by the extensive demand for constant testing protocols to cater to the safety and regulatory standards on a global level.

ANALYSIS BY TEST TYPE:

  • Environmental Test
    • Membrane Filtration (MF)
    • Multiple Tube Fermentation (MTF)
    • Enzyme Substrate Methods
  • Clinical Test
    • Polymerase Chain Reaction (PCR) Tests
    • Enzyme Immunoassays (EIA)
    • Others

Environmental testing (enzyme substrate methods) leads the market with around 61.8% of market share in 2025. This testing exhibits a critical role in assessing E. coli contamination in soil and water, with enzyme substrate methods emerging as an ideal testing procedure. Such methods utilize enzyme-based reactions to detect E. coli with elevated speed and specificity, facilitating feasible evaluations in crucial purposes, including agricultural safety and municipal water testing. Moreover, the cost-efficiency and user-friendliness of enzyme substrate methods have supported their broad range deployment, especially in regions with stringent environmental policies. Furthermore, the test includes adding a substrate to a sample, which exhibits a measurable fluorescence or color change upon interacting with the enzymes of E. coli. This technique significantly lowers the requirement for sophisticated laboratory infrastructure while sustaining resilience, establishing it as a keystone of environmental testing tactics. Additionally, constant innovations in enzyme-based technologies are poised to further solidify this segment's market share.

ANALYSIS BY END USER:

  • Hospitals and Clinics
  • Diagnostic Laboratories

Hospitals and clinics lead the market with around 65.8% of market share in 2025. This dominant end user is mainly impacted by their critical role in diagnosing and managing infections. These facilities handle a high volume of patients presenting symptoms of E. coli-associated illnesses, necessitating prompt and accurate diagnostic services. The prevalence of healthcare-associated infections (HAIs) further bolsters the demand for E. coli testing in clinical settings. Moreover, advanced diagnostic tools and rapid testing technologies are extensively employed in hospitals and clinics to ensure timely treatment, reducing complications and preventing outbreaks. In addition, the growing burden of foodborne diseases globally amplifies the need for reliable testing in healthcare institutions. The segment's leadership is further reinforced by stringent regulatory requirements mandating infection control and reporting, which place hospitals and clinics at the forefront of adopting comprehensive E. coli testing protocols.

REGIONAL ANALYSIS:

  • North America
    • United States
    • Canada
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Australia
    • Indonesia
    • Others
  • Europe
    • Germany
    • France
    • United Kingdom
    • Italy
    • Spain
    • Russia
    • Others
  • Latin America
    • Brazil
    • Mexico
    • Others
  • Middle East and Africa

In 2025, North America accounted for the largest market share of over 35.8%. This regional market is typically driven by a well-established healthcare infrastructure and resilient regulatory systems. The region's strict food safety frameworks, implemented by agencies like the CDC or FDA, have prompted the utilization of cutting-edge testing solutions across the key sectors, such as healthcare, food, or water. Heightening customer awareness related to foodborne illnesses further magnifies need for robust diagnostics. Moreover, technological innovations, encompassing automated detection systems and rapid testing kits, support the market expansion by providing effective and accurate solutions. In addition, substantial investments in research and development initiatives by leading market players fortify the region's domination on a global level. Furthermore, with accelerating incidences of E. coli outbreaks and a resilient emphasis on preemptive measures to guarantee public health, North America continues to bolster advancement and establish benchmarks for global E. coli testing strategies. For instance, as per industry reports, in the 2024-2025 fiscal year, 139 recalls were recorded in Canada, including those related to E. coli risks.

KEY REGIONAL TAKEAWAYS:

UNITED STATES E. COLI TESTING MARKET ANALYSIS

In 2025, United States accounted for the 87.60% of the market share in North America. E. coli infections are an important public health concern in the United States because it causes around 265,000 cases and 100 deaths per year. According to a research article, outbreaks and serious illnesses most often occur by Shiga toxin-producing E. coli, or about 40% of all infections from STEC are due to E. coli O157:H7. It shows the symptoms of infection in cases, including diarrhea, abdominal cramps, nausea, vomiting, and low-grade fever; its complications may be kidney failure or HUS. Young children, the elderly, and others who may be suffering from other illnesses fall within those at a higher risk of complications. E. coli further causes UTIs in up to 80% to 90% cases; this is especially seen among women. Recent outbreaks in the U.S. have included contaminated organic carrots and a severe outbreak linked to McDonald's Quarter Pounders in Mountain West states. Due to that, the demand for good E. coli testing in food safety, healthcare, and water treatment continues to grow.

EUROPE E. COLI TESTING MARKET ANALYSIS

The E. coli testing market in Europe is growing because of strict food safety regulations and increasing health care issues. According to the European Centre for Disease Prevention and Control, in 2023, the EU had the incidence of third-generation cephalosporin-resistant E. coli bloodstream infections at 10.35 per 100,000 people, which is a problem that is increasing with respect to antimicrobial resistance. The ECDC also reported that E. coli isolates harbouring the blaNDM-5 gene were associated with travel abroad from the EU/EEA to Africa and Asia countries. STEC continues to remain a risk, and a recommendation has been made through ECDC to maintain correct hand hygiene, food preparation, and washing of the vegetables. E. coli continues to be a prominent cause of bacterial infections related to enteritis, urinary tract infections, septicaemia, and neonatal meningitis. The above factors increase the demand for high-tech diagnostic tools. Moreover, the countries driving the most demand and innovation are Germany, France, and the UK. Furthermore, food traceability and sustainability have gained focus, leading to investment in novel testing technologies, hence supporting the growth of this market.

ASIA PACIFIC E. COLI TESTING MARKET ANALYSIS

Asia Pacific E. coli testing market is growing at a higher rate due to increased food production and awareness of food safety. According to China's National Health Commission, rapid urbanization and industrial agriculture increase foodborne illnesses including E. coli infections. India reported more than 500 outbreaks of diarrheal diseases in 2023. Among the patient samples, the most common bacteria isolated were E. coli. This means that the governments and private sectors are focusing more on installing efficient testing systems, especially for food and beverage companies. Multiplex PCR and lateral flow immunoassays are popular emerging technologies. In addition, states like Japan and South Korea are actively introducing the most advanced testing processes for food exports. Furthermore, India is increasingly improving the testing infrastructure for domestic purposes. Asia Pacific is considered to be the key region for E. coli testing market growth due to continuously increasing regulatory pressure.

LATIN AMERICA E. COLI TESTING MARKET ANALYSIS

Rising food safety concerns and increasing outbreaks of foodborne diseases in Latin America is anticipated to increase the demand for E. coli testing. According to a 2023 industrial report, Brazil is a leading country in Latin America in food production and exports, which fuels the E. coli testing market. The meta-analysis of 4,286 samples found that the general prevalence rate of Shiga toxin-producing E. coli (STEC) in Brazil was 1%, with the highest rate in Mato Grosso at 9%. Hot carcasses had the highest rate of positive samples for STEC at 8%. The Ministry of Health in Brazil has stressed the need for testing in the face of food safety requirements, whether for local consumption or for export. Argentina and Mexico are also investing more in food safety and diagnostics. Furthermore, as awareness of foodborne pathogens increases, the region experiences a shift toward faster, more automated testing solutions. Moreover, harsher regulations and standards instituted by governments also complement demand for advanced testing technologies in the market. Regional cooperation furthers the market growth process, as local manufacturers find partnerships with global players to enhance testing capabilities.

MIDDLE EAST AND AFRICA E. COLI TESTING MARKET ANALYSIS

The Middle East and Africa E. coli testing market is expected to grow due to increasing health issues and the increasing regulatory demands for food safety. According to the World Health Organization, foodborne diseases, including E. coli infection, are among the most concerning in the region and rise annually. The health ministry of Saudi Arabia in 2020 reported 1,270 cases of foodborne diseases, prompting the government to enforce stronger food safety regulations. Even in South Africa, where home-based producers export agricultural produce around the world, E. coli testing becomes important to reach international standards for food safety. Additionally, there is an expansion of both public and private investments in testing infrastructure within the region. Furthermore, the region's diverse geography as well as infrastructure challenges support widespread adoption of emerging technologies especially portable and rapid test kits.

COMPETITIVE LANDSCAPE:

The market is highly competitive, with leading players focusing on innovation and strategic partnerships to gain market share. Major companies are actively investing in the development of advanced rapid testing solutions to meet the growing demand for efficient and accurate diagnostics. Furthermore, the market features fierce competition among established as well as emerging firms providing niche solutions. In addition, competitive differentiation is typically bolstered by adherence to regulatory policies, technological innovations, and cost-efficiency. Moreover, several companies are augmenting their geographic reach and improving product lines to address the evolving demands of a broader customer base, further magnifying competition in this dynamic market. For instance, in July 2024, Alden, a biotechnology firm, launched its new food safety and quality testing method Suspended Simultaneous Sandwich Assay. This method can efficiently detect E. coli O157 in beef products.

The report provides a comprehensive analysis of the competitive landscape in the E. coli testing market with detailed profiles of all major companies, including:

  • Accugen Laboratories Inc.
  • Alere Inc. (Abbott Laboratories)
  • BD (Becton Dickinson and Company)
  • bioMerieux (INSTITUT MERIEUX)
  • Bio-RAD Laboratories Inc.
  • Enzo Life Sciences Inc. (Enzo Biochem Inc.)
  • Idexx Laboratories Inc.
  • Johnson & Johnson
  • Meridian Bioscience Inc.
  • Nanologix Inc.
  • Pro-Lab Diagnostics
  • Qiagen N.V.
  • Thermo Fisher Scientific Inc.

Key Questions Answered in This Report

1. What is E. coli testing?

2. How big is the E. coli testing market?

3. What is the expected growth rate of the global E. coli testing market during 2026-2034?

4. What are the key factors driving the global E. coli testing market?

5. What is the leading segment of the global E. coli testing market based on product?

6. What is the leading segment of the global E. coli testing market based on test type?

7. What is the leading segment of the global E. coli testing market based on end user?

8. What are the key regions in the global E. coli testing market?

9. Who are the key players/companies in the global E. coli testing market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global E. Coli Testing Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Product

  • 6.1 Consumables
    • 6.1.1 Market Trends
    • 6.1.2 Market Forecast
  • 6.2 Instruments
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast

7 Market Breakup by Test Type

  • 7.1 Environmental Test
    • 7.1.1 Market Trends
    • 7.1.2 Major Types
      • 7.1.2.1 Membrane Filtration (MF)
      • 7.1.2.2 Multiple Tube Fermentation (MTF)
      • 7.1.2.3 Enzyme Substrate Methods
    • 7.1.3 Market Forecast
  • 7.2 Clinical Test
    • 7.2.1 Market Trends
    • 7.2.2 Major Types
      • 7.2.2.1 Polymerase Chain Reaction (PCR) Tests
      • 7.2.2.2 Enzyme Immunoassays (EIA)
      • 7.2.2.3 Others
    • 7.2.3 Market Forecast

8 Market Breakup by End User

  • 8.1 Hospitals and Clinics
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 Diagnostic Laboratories
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast
  • 8.3 Others
    • 8.3.1 Market Trends
    • 8.3.2 Market Forecast

9 Market Breakup by Region

  • 9.1 North America
    • 9.1.1 United States
      • 9.1.1.1 Market Trends
      • 9.1.1.2 Market Forecast
    • 9.1.2 Canada
      • 9.1.2.1 Market Trends
      • 9.1.2.2 Market Forecast
  • 9.2 Asia Pacific
    • 9.2.1 China
      • 9.2.1.1 Market Trends
      • 9.2.1.2 Market Forecast
    • 9.2.2 Japan
      • 9.2.2.1 Market Trends
      • 9.2.2.2 Market Forecast
    • 9.2.3 India
      • 9.2.3.1 Market Trends
      • 9.2.3.2 Market Forecast
    • 9.2.4 South Korea
      • 9.2.4.1 Market Trends
      • 9.2.4.2 Market Forecast
    • 9.2.5 Australia
      • 9.2.5.1 Market Trends
      • 9.2.5.2 Market Forecast
    • 9.2.6 Indonesia
      • 9.2.6.1 Market Trends
      • 9.2.6.2 Market Forecast
    • 9.2.7 Others
      • 9.2.7.1 Market Trends
      • 9.2.7.2 Market Forecast
  • 9.3 Europe
    • 9.3.1 Germany
      • 9.3.1.1 Market Trends
      • 9.3.1.2 Market Forecast
    • 9.3.2 France
      • 9.3.2.1 Market Trends
      • 9.3.2.2 Market Forecast
    • 9.3.3 United Kingdom
      • 9.3.3.1 Market Trends
      • 9.3.3.2 Market Forecast
    • 9.3.4 Italy
      • 9.3.4.1 Market Trends
      • 9.3.4.2 Market Forecast
    • 9.3.5 Spain
      • 9.3.5.1 Market Trends
      • 9.3.5.2 Market Forecast
    • 9.3.6 Russia
      • 9.3.6.1 Market Trends
      • 9.3.6.2 Market Forecast
    • 9.3.7 Others
      • 9.3.7.1 Market Trends
      • 9.3.7.2 Market Forecast
  • 9.4 Latin America
    • 9.4.1 Brazil
      • 9.4.1.1 Market Trends
      • 9.4.1.2 Market Forecast
    • 9.4.2 Mexico
      • 9.4.2.1 Market Trends
      • 9.4.2.2 Market Forecast
    • 9.4.3 Others
      • 9.4.3.1 Market Trends
      • 9.4.3.2 Market Forecast
  • 9.5 Middle East and Africa
    • 9.5.1 Market Trends
    • 9.5.2 Market Breakup by Country
    • 9.5.3 Market Forecast

10 SWOT Analysis

  • 10.1 Overview
  • 10.2 Strengths
  • 10.3 Weaknesses
  • 10.4 Opportunities
  • 10.5 Threats

11 Value Chain Analysis

12 Porters Five Forces Analysis

  • 12.1 Overview
  • 12.2 Bargaining Power of Buyers
  • 12.3 Bargaining Power of Suppliers
  • 12.4 Degree of Competition
  • 12.5 Threat of New Entrants
  • 12.6 Threat of Substitutes

13 Price Analysis

14 Competitive Landscape

  • 14.1 Market Structure
  • 14.2 Key Players
  • 14.3 Profiles of Key Players
    • 14.3.1 Accugen Laboratories Inc.
      • 14.3.1.1 Company Overview
      • 14.3.1.2 Product Portfolio
    • 14.3.2 Alere Inc. (Abbott Laboratories)
      • 14.3.2.1 Company Overview
      • 14.3.2.2 Product Portfolio
    • 14.3.3 BD (Becton Dickinson and Company)
      • 14.3.3.1 Company Overview
      • 14.3.3.2 Product Portfolio
      • 14.3.3.3 Financials
      • 14.3.3.4 SWOT Analysis
    • 14.3.4 bioMerieux (INSTITUT MERIEUX)
      • 14.3.4.1 Company Overview
      • 14.3.4.2 Product Portfolio
      • 14.3.4.3 Financials
      • 14.3.4.4 SWOT Analysis
    • 14.3.5 Bio-RAD Laboratories Inc.
      • 14.3.5.1 Company Overview
      • 14.3.5.2 Product Portfolio
      • 14.3.5.3 Financials
      • 14.3.5.4 SWOT Analysis
    • 14.3.6 Enzo Life Sciences Inc. (Enzo Biochem Inc.)
      • 14.3.6.1 Company Overview
      • 14.3.6.2 Product Portfolio
    • 14.3.7 Idexx Laboratories Inc.
      • 14.3.7.1 Company Overview
      • 14.3.7.2 Product Portfolio
      • 14.3.7.3 Financials
      • 14.3.7.4 SWOT Analysis
    • 14.3.8 Johnson & Johnson
      • 14.3.8.1 Company Overview
      • 14.3.8.2 Product Portfolio
      • 14.3.8.3 Financials
      • 14.3.8.4 SWOT Analysis
    • 14.3.9 Meridian Bioscience Inc.
      • 14.3.9.1 Company Overview
      • 14.3.9.2 Product Portfolio
      • 14.3.9.3 Financials
      • 14.3.9.4 SWOT Analysis
    • 14.3.10 Nanologix Inc.
      • 14.3.10.1 Company Overview
      • 14.3.10.2 Product Portfolio
    • 14.3.11 Pro-Lab Diagnostics
      • 14.3.11.1 Company Overview
      • 14.3.11.2 Product Portfolio
    • 14.3.12 Qiagen N.V.
      • 14.3.12.1 Company Overview
      • 14.3.12.2 Product Portfolio
      • 14.3.12.3 Financials
      • 14.3.12.4 SWOT Analysis
    • 14.3.13 Thermo Fisher Scientific Inc.
      • 14.3.13.1 Company Overview
      • 14.3.13.2 Product Portfolio
      • 14.3.13.3 Financials
      • 14.3.13.4 SWOT Analysis

List of Figures

  • Figure 1: Global: E. Coli Testing Market: Major Drivers and Challenges
  • Figure 2: Global: E. Coli Testing Market: Sales Value (in Billion USD), 2020-2025
  • Figure 3: Global: E. Coli Testing Market: Breakup by Product (in %), 2025
  • Figure 4: Global: E. Coli Testing Market: Breakup by Test Type (in %), 2025
  • Figure 5: Global: E. Coli Testing Market: Breakup by End User (in %), 2025
  • Figure 6: Global: E. Coli Testing Market: Breakup by Region (in %), 2025
  • Figure 7: Global: E. Coli Testing Market Forecast: Sales Value (in Billion USD), 2026-2034
  • Figure 8: Global: E. Coli Testing (Consumables) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 9: Global: E. Coli Testing (Consumables) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 10: Global: E. Coli Testing (Instruments) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 11: Global: E. Coli Testing (Instruments) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 12: Global: E. Coli Testing (Environmental Test) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 13: Global: E. Coli Testing (Environmental Test) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 14: Global: E. Coli Testing (Clinical Test) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 15: Global: E. Coli Testing (Clinical Test) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 16: Global: E. Coli Testing (Hospitals and Clinics) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 17: Global: E. Coli Testing (Hospitals and Clinics) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 18: Global: E. Coli Testing (Diagnostic Laboratories) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 19: Global: E. Coli Testing (Diagnostic Laboratories) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 20: Global: E. Coli Testing (Other End Users) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 21: Global: E. Coli Testing (Other End Users) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 22: North America: E. Coli Testing Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 23: North America: E. Coli Testing Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 24: United States: E. Coli Testing Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 25: United States: E. Coli Testing Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 26: Canada: E. Coli Testing Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 27: Canada: E. Coli Testing Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 28: Asia Pacific: E. Coli Testing Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 29: Asia Pacific: E. Coli Testing Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 30: China: E. Coli Testing Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 31: China: E. Coli Testing Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 32: Japan: E. Coli Testing Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 33: Japan: E. Coli Testing Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 34: India: E. Coli Testing Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 35: India: E. Coli Testing Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 36: South Korea: E. Coli Testing Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 37: South Korea: E. Coli Testing Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 38: Australia: E. Coli Testing Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 39: Australia: E. Coli Testing Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 40: Indonesia: E. Coli Testing Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 41: Indonesia: E. Coli Testing Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 42: Others: E. Coli Testing Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 43: Others: E. Coli Testing Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 44: Europe: E. Coli Testing Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 45: Europe: E. Coli Testing Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 46: Germany: E. Coli Testing Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 47: Germany: E. Coli Testing Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 48: France: E. Coli Testing Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 49: France: E. Coli Testing Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 50: United Kingdom: E. Coli Testing Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 51: United Kingdom: E. Coli Testing Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 52: Italy: E. Coli Testing Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 53: Italy: E. Coli Testing Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 54: Spain: E. Coli Testing Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 55: Spain: E. Coli Testing Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 56: Russia: E. Coli Testing Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 57: Russia: E. Coli Testing Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 58: Others: E. Coli Testing Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 59: Others: E. Coli Testing Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 60: Latin America: E. Coli Testing Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 61: Latin America: E. Coli Testing Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 62: Brazil: E. Coli Testing Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 63: Brazil: E. Coli Testing Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 64: Mexico: E. Coli Testing Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 65: Mexico: E. Coli Testing Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 66: Others: E. Coli Testing Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 67: Others: E. Coli Testing Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 68: Middle East and Africa: E. Coli Testing Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 69: Middle East and Africa: E. Coli Testing Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 70: Global: E. Coli Testing Industry: SWOT Analysis
  • Figure 71: Global: E. Coli Testing Industry: Value Chain Analysis
  • Figure 72: Global: E. Coli Testing Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: E. Coli Testing Market: Key Industry Highlights, 2025 and 2034
  • Table 2: Global: E. Coli Testing Market Forecast: Breakup by Product (in Million USD), 2026-2034
  • Table 3: Global: E. Coli Testing Market Forecast: Breakup by Test Type (in Million USD), 2026-2034
  • Table 4: Global: E. Coli Testing Market Forecast: Breakup by End User (in Million USD), 2026-2034
  • Table 5: Global: E. Coli Testing Market Forecast: Breakup by Region (in Million USD), 2026-2034
  • Table 6: Global: E. Coli Testing Market Structure
  • Table 7: Global: E. Coli Testing Market: Key Players